Skip To Main Content
Zhengying Wang on Muck Rack

Zhengying Wang

As seen in: Wiley Online Library, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Zhengying

Contact Zhengying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A Dual‐Adjuvanted Parenteral‐Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS‐CoV‐2 in Mice

|
By Bhawana Pandey, Zhengying Wang, Angela Jimenez, Eshant Bhatia
| Wiley Online Library Verified
1 Introduction The COVID-19 pandemic continues to cause a global health crisis with frequent viral mutations and uncontrolled transmission in many parts of the world.
Open in Who Shared Issue with article?

A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice

|
By Bhawana Pandey, Angela Jimenez, Eshant Bhatia, Zhengying Wang
| BioRxiv
Abstract Existing parenteral SARS-CoV-2 vaccines produce only limited mucosal responses, which are essential for reducing transmission and achieving sterilizing immunity. Appropriately designed mucosal boosters could overcome the shortcomings of parenteral vaccines and enhance pre-existing systemic immunity.
Open in Who Shared Issue with article?
See all 2 articles